ArtNr |
E-AB-53116-60 |
Hersteller |
Elabscience
|
Menge |
60uL |
Kategorie |
|
Typ |
Antibody Polyclonal |
Applikationen |
WB, IHC, ELISA |
Specific against |
Human, Mouse, Rat |
Host |
Rabbit |
Isotype |
IgG |
ECLASS 10.1 |
32160702 |
ECLASS 11.0 |
32160702 |
UNSPSC |
12352203 |
Alias |
3-N-acetylglucosaminyltransferase lunatic fringe, Beta-1, Beta-13-N-acetylglucosaminyltransferase lunatic fringe, lfng, LFNG, O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase, SCDO3 |
Similar products |
LFNG, Beta-1, O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase, lfng, SCDO3, 3-N-acetylglucosaminyltransferase lunatic fringe, Beta-13-N-acetylglucosaminyltransferase lunatic fringe |
Lieferbar |
|
Research Areas |
Developmental Biology, Neuroscience, Stem Cells |
Synonyms |
3-N-acetylglucosaminyltransferase lunatic fringe, Beta-1, Beta-13-N-acetylglucosaminyltransferase lunatic fringe, lfng, LFNG, O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase, SCDO3 |
Swissprot |
Q8NES3 |
Background |
This gene is a member of the fringe gene family which also includes radical and manic fringe genes. They all encode evolutionarily conserved glycosyltransferases that act in the Notch signaling pathway to define boundaries during embryonic development. While their genomic structure is distinct from other glycosyltransferases, fringe proteins have a fucose-specific beta-1, 3-N-acetylglucosaminyltransferase activity that leads to elongation of O-linked fucose residues on Notch, which alters Notch signaling. This gene product is predicted to be a single-pass type II Golgi membrane protein but it may also be secreted and proteolytically processed like the related proteins in mouse and Drosophila (PMID: 9187150). Mutations in this gene have been associated with autosomal recessive spondylocostal dysostosis 3. Multiple transcript variants encoding different isoforms have been found for this gene. |
Concentration |
1.08 mg/mL |
Storage |
Store at -20C. Avoid freeze / thaw cycles. |
Immunogen |
Fusion protein of human LFNG |
Buffer |
PBS with 0.05% NaN3 and 40% Glycerol, pH7.4 |
Purification Method |
Antigen affinity purification |
Dilution |
WB 1:500-1:2000, IHC 1:50-1:200, ELISA 1:5000-1:10000 |
Conjugation |
Unconjugated |
Calculated MW |
42 kDa |
Observed MW |
Refer to figures |
Gene Accession |
BC014851 |
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.